Local Institution

Waratah, New South Wales NSW 2298

0 studies enrolling now · 7 studies all time

What they study most

Advanced Cutaneous Melanoma, Bladder Cancer, Bladder Neoplasms, High Risk Stage III Melanoma, Kidney Neoplasms, Lymphoma. Non-Hodgkin, Melanoma, Myeloid Leukemia, Chronic, Neoplasm, Bladder, Renal Cell Carcinoma, Transitional Cell Carcinoma, Ureter Neoplasms

Studies at this site

• An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma — Completed
• A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma — Completed
• Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) — Completed
• An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma — Completed
• Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma — Completed
• A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia — Completed
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium — Completed